NANO MRNA Co.,Ltd.
4571.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.80 | 0.40 | 0.42 | 0.27 |
| FCF Yield | 0.00% | -4.57% | -6.46% | -9.75% |
| EV / EBITDA | -10.79 | -13.70 | -12.14 | -7.61 |
| Quality | ||||
| ROIC | -22.66% | -18.85% | -22.99% | -30.42% |
| Gross Margin | 72.03% | 81.88% | 78.94% | 84.36% |
| Cash Conversion Ratio | 0.48 | 0.75 | 0.83 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | -18.73% | -19.94% | -13.58% | -21.84% |
| Free Cash Flow Growth | 100.00% | 46.18% | 38.21% | -41.03% |
| Safety | ||||
| Net Debt / EBITDA | 1.40 | 1.12 | 1.37 | 1.16 |
| Interest Coverage | 0.00 | -85.39 | -219.71 | -1,161.18 |
| Efficiency | ||||
| Inventory Turnover | 75.12 | 133.43 | 65.73 | 1.24 |
| Cash Conversion Cycle | 4.86 | 76.65 | 17.50 | 442.12 |